RxDoctor Payments Data

Corazon Coulter

Primary Care · Ventnor City, NJNPI 1508512427

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$3,039in general payments, 2019–2025

Across 89 payments — averaging $34.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$540
  • AbbVie$461
  • Aimmune Therapeutics, Inc.$419
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$378
  • Lilly USA, LLC$246
  • Phathom Pharmaceuticals, Inc.$227
  • plus $768 from 14 others

What the payments were for

  • Food & beverage$3,039100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,039 in reported general payments places this provider in the 85th percentile of 330 primary care providers in New Jersey.

See all primary care providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl82$41,573
Xtampza ErOxycodone Myristate50$20,722
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen425$13,745
Oxycodone Hcl454$8,141
Fentanyl12$3,215
Diclofenac Sodium14$2,350
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen99$2,308
Naloxone Hcl20$1,282
Morphine Sulfate ErMorphine Sulfate53$1,049
Gabapentin37$275
Methadone Hcl17$255
Tramadol Hcl14$176
Tizanidine Hcl30$143
Cyclobenzaprine Hcl20$132
Ibuprofen11$64

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$204$20,72250 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 330 primary care providers in New Jersey.

Other primary care in Ventnor City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →